612 related articles for article (PubMed ID: 23339520)
1. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
Cao F; Gao Y; Wang M; Fang L; Ping Q
Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
[TBL] [Abstract][Full Text] [Related]
2. Ethylene glycol-linked amino acid diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability and pharmacokinetics.
Cao F; Jia J; Yin Z; Gao Y; Sha L; Lai Y; Ping Q; Zhang Y
Mol Pharm; 2012 Aug; 9(8):2127-35. PubMed ID: 22352697
[TBL] [Abstract][Full Text] [Related]
3. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
[TBL] [Abstract][Full Text] [Related]
4. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
[TBL] [Abstract][Full Text] [Related]
5. Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
Fang L; Wang M; Gou S; Liu X; Zhang H; Cao F
J Med Chem; 2014 Feb; 57(3):1116-20. PubMed ID: 24422538
[TBL] [Abstract][Full Text] [Related]
6. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
[TBL] [Abstract][Full Text] [Related]
7. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
[TBL] [Abstract][Full Text] [Related]
8. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, transport and pharmacokinetics of 5'-amino acid ester prodrugs of 1-beta-D-arabinofuranosylcytosine.
Sun Y; Sun J; Shi S; Jing Y; Yin S; Chen Y; Li G; Xu Y; He Z
Mol Pharm; 2009; 6(1):315-25. PubMed ID: 19115956
[TBL] [Abstract][Full Text] [Related]
10. Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism.
Landowski CP; Song X; Lorenzi PL; Hilfinger JM; Amidon GL
Pharm Res; 2005 Sep; 22(9):1510-8. PubMed ID: 16132363
[TBL] [Abstract][Full Text] [Related]
11. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
Anand BS; Katragadda S; Mitra AK
J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
[TBL] [Abstract][Full Text] [Related]
13. Transport of levovirin prodrugs in the human intestinal Caco-2 cell line.
Li F; Hong L; Mau CI; Chan R; Hendricks T; Dvorak C; Yee C; Harris J; Alfredson T
J Pharm Sci; 2006 Jun; 95(6):1318-25. PubMed ID: 16634069
[TBL] [Abstract][Full Text] [Related]
14. Chemical and enzymatic stability of amino acid prodrugs containing methoxy, ethoxy and propylene glycol linkers.
Gupta D; Gupta SV; Lee KD; Amidon GL
Mol Pharm; 2009; 6(5):1604-11. PubMed ID: 19566080
[TBL] [Abstract][Full Text] [Related]
15. A carrier-mediated prodrug approach to improve the oral absorption of antileukemic drug decitabine.
Zhang Y; Sun J; Gao Y; Jin L; Xu Y; Lian H; Sun Y; Sun Y; Liu J; Fan R; Zhang T; He Z
Mol Pharm; 2013 Aug; 10(8):3195-202. PubMed ID: 23822717
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.
Tsume Y; Hilfinger JM; Amidon GL
Mol Pharm; 2008; 5(5):717-27. PubMed ID: 18652477
[TBL] [Abstract][Full Text] [Related]
17. Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.
Jain R; Duvvuri S; Kansara V; Mandava NK; Mitra AK
Int J Pharm; 2007 May; 336(2):233-40. PubMed ID: 17207946
[TBL] [Abstract][Full Text] [Related]
18. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.
Tong HH; Du Z; Wang GN; Chan HM; Chang Q; Lai LC; Chow AH; Zheng Y
Int J Pharm; 2011 Feb; 404(1-2):148-58. PubMed ID: 21094233
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells.
Katragadda S; Jain R; Kwatra D; Hariharan S; Mitra AK
Int J Pharm; 2008 Oct; 362(1-2):93-101. PubMed ID: 18638532
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.
Gupta SV; Gupta D; Sun J; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
Mol Pharm; 2011 Dec; 8(6):2358-67. PubMed ID: 21905667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
